Extension of positive list expected for Horses
The revision of the EU legislation on residues of pharmacologically active substances in foods,has lead the European Parliament to address the issue of the (un-)availability of veterinary medicinal products. One of the amendments tabled by Mrs. Avril Doyle, the Parliament’s rapporteur for the residues legislation, and adopted by the Parliament, relates to article 10 of the medicines Directive. (EU/2001/82).
This article gives the veterinarian the possibility- in case no medicine is authorised for a certain indication - to use products authorised for other species or indications. In addition to that, the provision allows for the use of a certain number of listed substances for horses, without excluding these animals from the food chain.
Until now, one of the criteria to be listed is that the substance has to be essential for the treatment of equidae. According to the amendment, the scope of the list will be extended with substances, which bring added clinical benefit compared to other treatment options available for equidae. The new provision is expected to come into force this summer. The European Federation of Equine Veterinary Associations (FEEVA) together with FVE already started to make a proposal on how the amendment could be implemented.